Jim Cramer Hungers for Panera, Vodafone, and These 3 Stocks

Jim Cramer made the following calls on October 1st, 2013. What do you think about his picks?

Panera Bread Co. (NASDAQ:PNRA): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on August 12, 2013. The stock’s 52-week high is $194.77, and its 52-week low is $153.65. Cramer was bullish on Panera, the restaurant that has seen its stock price rise fantastically over the last few years. However, concerns have emerged since the company peaked this past May, with many believing that customers find the food overpriced, causing a drop in same-store sales. Cramer was undeterred, though, claiming that his opinion was that the stock would bounce.

PNRA 20131002

Vodafone Group plc (NASDAQ:VOD): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on August 20, 2013. The stock’s 52-week high is $35.36, and its 52-week low is $24.42. Cramer said that he remains a buyer of Vodafone. In the wake of Vodafone’s deal with Verizon (NYSE:VZ), by which Verizon bought out Vodafone’s stake in the company, some think that Vodafone is being eyed by AT&T (NYSE:T) as  potential acquisition.

VOD 20131002

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Sell on March 8, 2013. The stock’s 52-week high is $10.51, and its 52-week low is $2.23. A biotech company that has seen its stock steadily rise over the last year, Keryx was discussed by Cramer as part of a list of biotech firms that are worth looking into. Cramer noted that the biotech sector was ripe for exploration while attention is focused on Washington and the gridlock that Congress has fallen into.

KERX 20131002

Royal Bank of Scotland Group plc (NYSE:RBS): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on September 10, 2013. The stock’s 52-week high is $12.06, and its 52-week low is $8.12. Cramer was optimistic about the Royal Bank of Scotland, reiterating his buy ranking on the stock from earlier last month. Cramer noted that there was tremendous value in the company, and that it was cheap to get in to.

RBS 20131002

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on September 30, 2013. The stock’s 52-week high is $33.75, and its 52-week low is $7.35. It didn’t take long for Cramer to give the nod to NPS Pharmaceuticals a second time. Not only is Cramer a fan of the sector, as it is unlikely to be severely affected by political news, but he has pointed to NPS’s strong performance over the past few months as a sign of the company’s sound fundamentals in the industry.

NPSP 20131002

Don’t Miss: What Does the Shutdown Mean for the Debt Ceiling?